Patients are savvier and more engaged than ever before in their healthcare. As the biopharma industry strives to deliver more patient-centric decentralized clinical trials (DCTs), a design thinking approach can help sponsors more purposefully identify and deploy the trial models and technologies that most enhance patients' experience.
In this webinar, IQVIA experts will share how to put patient-centricity into practice. Reconsider common assumptions by gathering insight into patients' needs and experiences before protocol design. Improve study outcomes by applying those insights to strategically inform the right DCT study model and technologies for your study.
The result? Higher retention, improved engagement, and faster, higher quality study results.
Who should attend - any clinical operations professional interested in learning how patient focused DCT trials improve outcomes.
Krista Bradley
RN, MBA, VP & General Manager, IQVIA Research Nursing and Phlebotomy Solutions, IQVIA
Melissa Easy
VP of Clinical Technologies, IQVIA R&D Solutions
Kelly Sanford
Global Head of Site Operations, IQVIA Decentralized Trial Solutions.
2:00pm GMT / 3:00pm CET / 9:00am EST
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
